GET PROPEL
Stay Informed
GET PROPEL
Stay Informed
You are being directed to a third-party website. Please note that this third-party website is not controlled by PROPELOpens.com.
Thank you for visiting our site.
The following resources may be helpful to further educate yourself about PROPEL and how to implement PROPEL into your practice
Reimbursement
Discover resources and education regarding coding and billing, and reimbursement of the PROPEL family of implants.
Effective April 1, 2021, the CMS has made changes to the HCPCS code set for PROPEL implants.
The new S-code for PROPEL implants, across all settings of
care, is S1091.
CMS, Centers for Medicare & Medicaid Services; HCPCS, Healthcare Common Procedure Coding System; MAC, Medicare Administrative Contractor; OPPS, Outpatient Prospective Payment System.
Videos
Hear from real PROPEL implant users
Hear directly from patients on how the PROPEL family of implants has helped them with chronic rhinosinusitis (CRS) symptoms.
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
Peer-to-Peer Case Studies
Explore this video library, featuring medical experts, to learn the benefits and risks of incorporating PROPEL implants into your sinus surgeries.
WATCH VIDEO
Maxillary Case Study
Watch Dr. McKinney discuss the case of a 59-year-old woman with CRS and nasal polyposis refractory to medical management and prior maxillary sinus surgery.
WATCH VIDEO
PROPEL in the Office
Watch Dr. Matheny discuss the postoperative use of PROPEL in the office, following a total bilateral ethmoidectomy in an ambulatory surgery center.
WATCH VIDEO
Ethmoid Case Study
Watch Dr. Raithatha discuss the rationale for using PROPEL Mini deployed with the Straight Delivery System, in a 71-year-old male suffering from ethmoid sinus disease that is refractory to medical management.
WATCH VIDEO
How to Effectively Talk to Patients About PROPEL
Dr. Scott Robertson speaks from extensive experience about setting expectations with patients.
Brochures
Case Studies
Ethmoid Sinus Case Studies
Learn more about the benefits of PROPEL and PROPEL Mini.
Resources for Your Patients
Intersect ENT is proud to offer our practices with turnkey and customizable resources to help educate the community, patients, and referral sources about the advanced treatment options to take action against chronic sinusitis with PROPEL.
Including PROPEL in your patient outreach strategy is critical to showcase your commitment to providing safe, effective, and highly researched technology. By engaging patients through multiple touch-points and channels, you can energize your patient base to proactively ask for the newest technology.
VISIT WEBSITE
GET PROPEL
Stay Informed
This site is intended for healthcare professionals in the United States
The PROPEL sinus implants are intended to maintain patency and locally deliver steroid to the sinus mucosa in patients ≥18 years of age following sinus surgery: PROPEL for the ethmoid sinus, PROPEL Mini for the ethmoid sinus/frontal sinus opening, and PROPEL Contour for the frontal/maxillary sinus ostia. Contraindications include patients with confirmed hypersensitivity or intolerance to mometasone furoate (MF) or hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of the implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. For full prescribing information see IFU at www.IntersectENT.com/technologies/. Rx only.
© 2024 Intersect ENT, Inc. All rights reserved. Intersect ENT and PROPEL are registered trademarks of Intersect ENT, Inc. in the United States and other countries. MPM-11549 Rev 7.0
The above-identified implants, delivery systems, and/or the use of the above-identified implants/delivery systems in a method may be covered by one or more U.S. and/foreign patents, found at intersectent.com/patents.